Application 215401

Type
NDA
Sponsor
NOVEN PHARMS INC

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001XELSTRYMDEXTROAMPHETAMINESYSTEM; TRANSDERMAL4.5MG/9HRNoNo
002XELSTRYMDEXTROAMPHETAMINESYSTEM; TRANSDERMAL9MG/9HRNoNo
003XELSTRYMDEXTROAMPHETAMINESYSTEM;TRANSDERMAL13.5MG/9HRNoNo
004XELSTRYMDEXTROAMPHETAMINESYSTEM;TRANSDERMAL18.5MG/9HRNoNo

NDC Listings For This Application#

NDC, Name, Nonproprietary name table
NDCNameNonproprietary nameLabelerMarketing categoryStatus
68968-0205XELSTRYMDEXTROAMPHETAMINENoven Therapeutics, LLCNDACurrent
68968-0210XELSTRYMDEXTROAMPHETAMINENoven Therapeutics, LLCNDACurrent
68968-0215XELSTRYMDEXTROAMPHETAMINENoven Therapeutics, LLCNDACurrent
68968-0220XELSTRYMDEXTROAMPHETAMINENoven Therapeutics, LLCNDACurrent

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
83513SUPPL 2025-09-25
83512SUPPL 2025-09-25
83465SUPPL 2025-09-25
80467SUPPL 2024-12-02
80465SUPPL 2024-12-02
75807SUPPL 2023-10-17
71833SUPPL2022-08-17
71817SUPPL2022-08-17
70994ORIG2022-05-04
70602ORIG2022-03-25
70589ORIG2022-03-23